Showing results (1-10 of 65) with videos related to
Sort By:
Pageof 7
International Journal of Laboratory Hematology|May 16, 2015
Advances in the pathogenesis and diagnosis of multiple myelomaM Chesi, P L BergsagelBlood|February 7, 2001
Activated fibroblast growth factor receptor 3 is an oncogene that contributes to tumor progression in multiple myelomaM Chesi, L A Brents, S A Ely, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 9, 2000
Recurrent immunoglobulin gene translocations identify distinct molecular subtypes of myelomaM Chesi, W M Kuehl, P L BergsagelCancer Research|October 1, 1996
Selective expression of one c-myc allele in two human myeloma cell linesW M Kuehl, L A Brents, M Chesi, et al.Molecular Cell|February 20, 1999
Insertion of excised IgH switch sequences causes overexpression of cyclin D1 in a myeloma tumor cellA Gabrea, P L Bergsagel, M Chesi, et al.Current Topics in Microbiology and Immunology|January 1, 1997
IgH translocations in multiple myeloma: a nearly universal event that rarely involves c-mycP L Bergsagel, E Nardini, L Brents, et al.Current Topics in Microbiology and Immunology|January 1, 1997
Dysregulation of c-myc in multiple myelomaW M Kuehl, L A Brents, M Chesi, et al.Blood|October 27, 1998
The t(4;14) translocation in myeloma dysregulates both FGFR3 and a novel gene, MMSET, resulting in IgH/MMSET hybrid transcriptsM Chesi, E Nardini, R S Lim, et al.Proceedings of the National Academy of Sciences of the United States of America|November 26, 1996
Promiscuous translocations into immunoglobulin heavy chain switch regions in multiple myelomaP L Bergsagel, M Chesi, E Nardini, et al.Nature Genetics|July 1, 1997
Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3M Chesi, E Nardini, L A Brents, et al.Pageof 7